Tech Company Financing Transactions

Skyhawk Therapeutics Funding Round

Skyhawk Therapeutics secured a $40 million funding round on 6/27/2018. Investors included Agent Capital, Alexandria Venture Investments and Greatpoint Ventures Innovation Fund.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

35 Gatehouse Dr.
Waltham, MA 02451
USA

Phone

(617) 858-0041

Website

www.skyhawktx.com

Email Address

[email protected]

Overview

Skyhawk's founders are leading scientists in the development of small molecule therapeutics that correct RNA expression. Our proprietary technology enables the rational design of small molecules that target the RNA splicing process. We are now developing drug candidates for cancer, neurological disease, and rare disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Friedrich Metzger

        

Chief Executive Officer

William Haney

        

Chief Financial Officer

Gary Martell

        

Chief Scientific Officer

Kathleen McCarthy

        

Vice President

Michael Luzzio

        

Vice President

Sergey Paushkin

        

VP - Finance

Maura McCarthy

        

Browse more venture capital transactions:

Prev: 6/27/2018: Unison Home Ownership Investors venture capital transaction
Next: 6/27/2018: Aclima venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on tech company VC transactions. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary